logo

Greenwich Lifesciences, Inc. (GLSI)



Trade GLSI now with
  Date
  Headline
6/7/2021 6:33:45 AM Greenwich LifeSciences Publishes Additional Positive Safety Data From GP2 Phase IIb Trial At ASCO
4/14/2021 6:04:01 AM Greenwich LifeSciences Announces Update Of GP2 Phase III Clinical Trial Design At AACR Annual Meeting
4/12/2021 5:55:28 AM Greenwich LifeSciences Presents Phase IIb Poster, Published April 10th At 2021 AACR Annual Meeting
4/9/2021 5:06:22 AM Greenwich LifeSciences Reports Abstract Results Of 5-yr Immune Response Data Of GP2 Phase 2b Clinical Trial At AACR
12/18/2020 6:02:49 AM Greenwich LifeSciences Prices Public Offering With Gross Proceeds Expected To Be $26.4 Mln
12/15/2020 6:13:46 AM Greenwich LifeSciences Enters Option Agreement With Westport Bio
12/11/2020 6:03:36 AM Greenwich LifeSciences Report Poster Presentation On GP2 Phase III Clinical Trial Design For Recurring Breast Cancer
12/3/2020 7:28:41 AM Greenwich LifeSciences Enters Contract For The Final Formulation And Filling Of GP2 Into Vials
11/23/2020 7:27:22 AM Greenwich LifeSciences Announces Publication Of Second Abstract Of GP2 Phase III Clinical Trial
11/18/2020 7:13:52 AM Greenwich LifeSciences Announces Publication Of Positive Phase IIb Clinical Trial Data For GP2